Related Experiment Video
Updated: Sep 15, 2025

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
Biochemical and molecular evaluation of resveratrol and selenium nanoparticles in managing type 2 diabetes and its
Aya Y Soliman1, Nihal M Elguindy1, Abdulrahman M Saleh2,3
1Department of Biochemistry, Faculty of Science, Alexandria University, Alexandria, 21511, Egypt.
Abstract:
The therapeutic potential of dietary polyphenols, such as resveratrol (Res) and elemental selenium nanoparticles (SeNPs), has gained increasing attention for the treatment and management of type 2 diabetes mellitus (T2DM). In this study, we investigated a novel therapeutic strategy using chitosan-stabilized Res/SeNPs (CS/Res/SeNPs) in a mouse model of T2DM induced by high-fat diet (HFD) feeding combined with multiple low-dose streptozotocin (STZ) injections. We evaluated the effects of these nanoparticles on glucose and insulin levels, oxidative/antioxidant balance, expression of apoptotic and anti-apoptotic genes, and inflammatory mediators using biochemical, histopathological, and molecular docking analyses. Treatment with free Res, CS/Res/SeNPs-5, CS/Res/SeNPs-10, and Metformin (Met) improved hyperglycemia, insulin resistance (IR), and dyslipidemia, and normalized elevated liver and kidney biomarkers. These treatments also exhibited anti-inflammatory, antioxidant, and anti-apoptotic effects. CS/Res/SeNPs-10 showed the most potent hepatoprotective and anti-diabetic effects. The docking results revealed that Res binds to key insulin signaling proteins, such as phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR). Collectively, our findings highlight the therapeutic promise of CS/Res/SeNPs in managing T2DM complications and suggest a cost-effective strategy to enhance health outcomes and quality of life in diabetic patients.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Psychoneuroimmunology: Diabetes and Cancer

